Search by job, company or skills
Work Schedule
Standard (Mon-Fri)Environmental Conditions
OfficeThermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $40 billion and extensive investment in R&D. Our Mission is to enable our customers to make the world healthier, cleaner and safer. The customers we serve fall within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. Our innovations drive scientific breakthroughs, from pioneering research to routine testing and real-world applications.
How will you make an impact
You will be a cornerstone in developing and ensuring reliable, accurate and robust algorithms. You will develop innovative algorithms, create frameworks and tools that enables comprehensive validation and characterization of algorithms, ultimately driving excellence in our product offerings. You will collaborate with and learn from a dedicated team of algorithm and software developers, revolutionizing healthcare through low-cost and high throughput diagnostic systems.
What will you do
How will you get here
Education
BSin Computer Sciences, Mathematics, Statistics ora relatedfielda Master's degreeis highlypreferred
Experience
Knowledge, Skills, Abilities
Date Posted: 27/08/2025
Job ID: 124787411
Thermo Fisher Scientific Inc. is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including: Life Technologies Corporation (2013), Alfa Aesar (2015),Affymetrix (2016),FEI Company (2016), BD Advanced Bioprocessing (2018),and PPD (2021).
As of 2017, the company had a market capitalization of $21 billion and was a Fortune 500 company. Annual revenue in 2021 was US$39.21 billion.
In March 2020, Thermo Fisher Scientific received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic.